AGA Family of Websites:

Blog: Addition of nucleic acid polymers improves outcomes of patients with HBV infection

Researchers report in Gastroenterology that the addition of nucleic acid polymers to tenofovir disoproxil fumarate and pegIFN therapy significantly increased rates of HBsAg loss and seroconversion, and functional cure, after therapy.
HBV Gastroenterology editorial figure
HBV Gastroenterology editorial figure

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.